TELO (STOCKS)
Telomir Pharmaceuticals, Inc. Common Stock
$1.060000
-0.050000 (-4.50%)
Prev close: $1.110000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Erez Aminov
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $72.56M
- Employees
- 5
- P/E (TTM)
- -3.60
- P/B (TTM)
- 7.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.28 | $-0.07 | -0.2086 | -292.16% |
|
Sep 2025 (Q3)
|
$-0.03 | $-0.07 | +0.0414 | +57.98% |
|
Jun 2025 (Q2)
|
$-0.17 | $-0.08 | -0.0884 | -108.33% |
|
Mar 2025 (Q1)
|
$-0.07 | $-0.10 | +0.0320 | +31.37% |
Financial Statements
| Assets | $5.79M |
| Current Assets | $5.79M |
| Prepaid Expenses | $229.03K |
| Other Current Assets | $5.56M |
| Noncurrent Assets | $0.00 |
| Liabilities | $827.31K |
| Current Liabilities | $827.31K |
| Noncurrent Liabilities | $0.00 |
| Equity | $4.96M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.96M |
| Liabilities And Equity | $5.79M |